- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04091308
Individualized Physical Exercise Training and Enhanced Protein Intake in Older Citizens During Municipality-based Rehabilitation
Study Overview
Status
Conditions
Detailed Description
Successful rehabilitation of the growing number of elderly citizens can lead to preservation of functional independence and improvement in the quality of life.
The aim of the study is to investigate the effect of an individually tailored physical exercise training program combined with increased protein intake in order to improve measures on all three ICF levels (International Classification of Functioning, Disability, and Health). By conducting the study in a real-life clinical setting, research is translated into practice involving health professionals and the target group in the development of new knowledge on how to enhance the outcome of rehabilitation, thereby increasing the overall capacity of the elderly citizen, and decreasing the expenditure of health-services.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Zealand
-
Slagelse, Zealand, Denmark, 4200
- Sundhed og Træning
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
All citizens that are referred to the health/rehabilitation center age 65 years and older from Slagelse municipality will be invited to a screening interview with a physiotherapist after which the participant will be asked to join the study if not subject to one of the following exclusion criteria's:
Exclusion Criteria:
- inability to speak or read Danish,
- renal diseases,
- active cancer,
- upper or lower limp amputations,
- milk/lactose allergy or intolerance,
- hypertension >180/110,
- pacemaker/other implanted electrical stimulants (due to Bio-Impedance Analysis),
- progressive somatic or psychiatric diseases which can affect the course of training,
- referred to rehabilitation primarily due to gynecological and neurological conditions (apoplexies) or surgeries where movement restrictions are recommended,
- daily medication that may have an impact on muscle protein synthesis,
- alcohol intake greater than 14 units per week,
- discouragement from a general practitioner.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Usual Care
Usual care involves physiotherapeutic rehabilitation in an unknown format, and will, therefore, be monitored closely and described accordingly.
|
Usual care involves physiotherapeutic rehabilitation in an unknown format, and will, therefore, be monitored closely and described accordingly.
|
|
Experimental: Usual Care with Protein Supl.
Usual care involves physiotherapeutic rehabilitation in an unknown format, and will, therefore, be monitored closely and described accordingly.
|
The intake of protein supplementation (ARLA PROTINO) will be consumed by participants in the form of protein-enriched yogurts for easy consumption two times daily, with each bottle containing 14 g of protein.
Other Names:
|
|
Experimental: Individualized Physical Exercise Training with Protein Supl.
This group is also called EXER group, and will receive individually tailored physical exercise programs, based on their strength and weaknesses from the baseline testing.
|
Besides getting prescribed individualized physical exercise training programs, this group will consume protein supplementation (ARLA PROTINO) in form of protein enriched yogurts for easy consumption, two times daily, with each bottle containing 14 g of protein.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Short Musculoskeletal Function Assessment (SMFA) - Dysfunction Index
Time Frame: Change from: baseline to 3 months (primary endpoint) and 12 months
|
Self reported
|
Change from: baseline to 3 months (primary endpoint) and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean change from baseline in mobility with The New Mobility Score
Time Frame: Change from: baseline to 3 months and 12 months
|
The New Mobility Score assesses the patient's walking function inside, outside, and during shopping.
Including whether a walking aid is used.
The NMS provides a composed score of the participants' mobility.
Each question is scored between 0-3 points, depending on the degree of help.
The total possible score is between 0 and 9 points.
|
Change from: baseline to 3 months and 12 months
|
|
Mean change from baseline in the PRISMA-7 score
Time Frame: Change from: baseline to 3 months and 12 months
|
The PRISMA-7 questionnaire is composed of seven items and is used to indicate frailty among participants - each question scores either 0 or 1 points.
The total possible score is between 0 and 7 points.
|
Change from: baseline to 3 months and 12 months
|
|
Mean change from baseline in the Tilburg Frailty Scale score
Time Frame: Change from: baseline to 3 months and 12 months
|
The Tilburg Frailty Scale is a questionnaire with a bio-psycho-social approach, which measures frailty. It is composed of 15 multidimensional questions, regarding the physical, psychological, and social aspects of human functioning. Scoring range is between 0-15 points. |
Change from: baseline to 3 months and 12 months
|
|
Mean change from baseline in health-related quality of life on SF-36
Time Frame: Change from: baseline to 3 months and 12 months
|
The SF-36 is a generic questionnaire that measures health-related quality of life in the past four weeks.
The questionnaire consists of 36 questions which are divided into eight sub-scales and summarized in 2 sum scores.
|
Change from: baseline to 3 months and 12 months
|
|
Measure of pain, physical activity level and educational level
Time Frame: Change from: baseline to 3 months and 12 months
|
A survey with self-formulated questions regarding name, sex, personal ID (CPR number), educational level, the region of pain the last three months (marked on a body chart), pain intensity at the site of pain, and physical activity level will also be collected.
|
Change from: baseline to 3 months and 12 months
|
|
Mean change from baseline in weight
Time Frame: Change from: baseline to 3 months and 12 months
|
Weight (in kilograms).
Weight and height will be combined to report BMI in kg/m^2.
|
Change from: baseline to 3 months and 12 months
|
|
Measure of height at baseline
Time Frame: Baseline
|
Height (in meters).
Weight and height will be combined to report BMI in kg/m^2.
|
Baseline
|
|
Mean change from baseline in blood pressure
Time Frame: Change from: baseline to 3 months and 12 months
|
Systolic and diastolic blood pressure (mmHg) will be measured using the Omron HBP 1100 blood pressure and resting heart rate monitor.
|
Change from: baseline to 3 months and 12 months
|
|
Mean change from baseline in resting heart rate
Time Frame: Change from: baseline to 3 months and 12 months
|
Resting heart rate (in beats per minute) will be measured using the Omron HBP 1100 blood pressure and resting heart rate monitor.
|
Change from: baseline to 3 months and 12 months
|
|
Mean change from baseline in body composition measured with a bioimpedance device
Time Frame: Change from: baseline to 3 months and 12 months
|
The electrical bioimpedance device used in the present study to measure changes in body composition is the "Tanita 9MC-780U Multi Frequency Segmental Body Composition Analyzer". Lean body mass (in kilograms), fat percentage (described as a percentage of the total body mass), total body water (described as a percentage of the total body mass), a visceral fat indicator will be reported |
Change from: baseline to 3 months and 12 months
|
|
Mean change from baseline in the basic metabolic rate (BMR)
Time Frame: Change from: baseline to 3 months and 12 months
|
BMR will be estimated by a bioelectrical impedance analysis device "Tanita 9MC-780U Multi Frequency Segmental Body Composition Analyze".
|
Change from: baseline to 3 months and 12 months
|
|
Mean change from baseline of Waist-To-Hip ratio
Time Frame: Change from: baseline to 3 months and 12 months
|
The circumference of the waist (in centimeters) will be divided with the circumference of the hip (in centimeters) to report the Waist-to-hip ratio.
|
Change from: baseline to 3 months and 12 months
|
|
Mean change from baseline in maximal isometric voluntary contraction of leg extension
Time Frame: Change from: baseline to 3 months and 12 months
|
A maximal isometric voluntary contraction (in newtons) for knee extension will be performed using a strain gauge.
|
Change from: baseline to 3 months and 12 months
|
|
Mean change from baseline in handgrip strength
Time Frame: Change from: baseline to 3 months and 12 months
|
The handgrip strength (in kilograms) will be measured using a hydraulic handgrip dynamometer (SAEHAN).
|
Change from: baseline to 3 months and 12 months
|
|
Mean change from baseline in leg press strength
Time Frame: Change from: baseline to 3 months and 12 months
|
Five repetitions maximum (RM) strength tests will be performed in the leg press (in kilograms) to calculate 1 RM.
|
Change from: baseline to 3 months and 12 months
|
|
Mean change from baseline in knee extension strength
Time Frame: Change from: baseline to 3 months and 12 months
|
Five repetitions maximum (RM) strength tests will be performed in knee extension (in kilograms) to calculate 1 RM.
|
Change from: baseline to 3 months and 12 months
|
|
Mean change from baseline in calf extension strength
Time Frame: Change from: baseline to 3 months and 12 months
|
Five repetitions maximum (RM) strength tests will be performed in the calf extension (in kilograms) to calculate 1 RM.
|
Change from: baseline to 3 months and 12 months
|
|
Mean change from baseline in function measured with the 2 minutes walk test (2MWT)
Time Frame: Change from: baseline to 3 months and 12 months
|
The 2MWT will measure the distance (in meters) a person can walk in 2 minutes.
Gaits speed will be calculated by dividing the covered distance with the time (120 seconds).
|
Change from: baseline to 3 months and 12 months
|
|
Mean change from baseline in heart rate during 2 minutes walk test (2MWT)
Time Frame: Change from: baseline to 3 months and 12 months
|
Heart rate (in BPM) will be measured (using the Apple Watch serie 5) before and right after the 2MWT.
|
Change from: baseline to 3 months and 12 months
|
|
Mean change from baseline in heart rate before and after the 2 minutes walk test (2MWT)
Time Frame: Change from: baseline to 3 months and 12 months
|
Heart rate (in BPM) will be measured (using the Apple Watch serie 5) before and right after the 2MWT.
|
Change from: baseline to 3 months and 12 months
|
|
Mean change from baseline in The Borg Rating of Perceived Exertion before and after the 2 minutes walk test (2MWT)
Time Frame: Change from: baseline to 3 months and 12 months
|
The Borg Rating of Perceived Exertion will be used to estimate the activity intensity before and right after the 2MWT.
|
Change from: baseline to 3 months and 12 months
|
|
Mean change from baseline in function measured with the Timed Up and Go test (TUG)
Time Frame: Change from: baseline to 3 months and 12 months
|
Time is noted (in seconds) on how long it takes to get up from a chair, walk 3 meters, turn around and go back to the chair and sit down again.
|
Change from: baseline to 3 months and 12 months
|
|
Mean change from baseline in balance measured with the Tandem test
Time Frame: Change from: baseline to 3 months and 12 months
|
A measure of static balance will be performed using a Tandem test.
The participants will be tested in three positions for 10 seconds each (feet together, semi tandem and full tandem).
Time is noted (in seconds) for how long the participant can stand in each position.
|
Change from: baseline to 3 months and 12 months
|
|
Balance and reaction time for upper and lower extremity
Time Frame: Change from: baseline to 3 months and 12 months
|
Measures for balance and reaction time will be collected using the "Fysiometer," and the protocols within the "Fysiometer" software will be followed.
|
Change from: baseline to 3 months and 12 months
|
|
Protein and energy intake
Time Frame: Change from: baseline, week 3, week 6, week 9, 3 months and 12 months
|
During the 12-week intervention period, protein and energy intake will be estimated based on the average of four 24-hour dietary recall interviews, either by home visits or by phone.
Dietary interviews will also be conducted at 12 month follow-up.
|
Change from: baseline, week 3, week 6, week 9, 3 months and 12 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Sanel Teljigovic, PhD student, University College Absalon & University of Southern Denmark
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 8045-00052B (Danish Council for Independent Research)
- SJ-758 (Other Identifier: Ethics Committee, Region Zealand, Denmark)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rehabilitation
-
Mississippi State UniversityUniversity of Mississippi Medical CenterNot yet recruitingPostoperative Rehabilitation | Hand Injury RehabilitationUnited States
-
Ankara Etlik City HospitalRecruitingStroke Rehabilitation | Stroke Rehabilitation and CaregiversTurkey (Türkiye)
-
Asan Medical CenterRecruitingPulmonary Rehabilitation | Cardiac RehabilitationKorea, Republic of
-
Westfälische Wilhelms-Universität MünsterNational Paralympic Committee Germany (NPCG)CompletedCardiac Rehabilitation | Feasibility Studies | Organization and Administration | Rehabilitation ExerciseGermany
-
University Hospital, ToursCompletedPulmonary Rehabilitation | Respiratory RehabilitationFrance
-
Suleyman Demirel UniversityCompleted
-
Orton Orthopaedic HospitalCompleted
-
Richard Watson, PTCompletedMedial Patellar Femoral Ligament Reconstruction Rehabilitation | Anterior Cruciate Ligament Reconstruction RehabilitationUnited States
-
Stanford UniversityRecruitingRehabilitationUnited States
-
Cairo UniversityRecruiting
Clinical Trials on Usual Care
-
Charite University, Berlin, GermanyCompletedMultiple Sclerosis | FatigueGermany
-
Charite University, Berlin, GermanyMammazentrum Hamburg am Krankenhaus Jerusalem, Germany; Dorit und Alexander...Completed
-
European Institute for Evidence Based Osteopathic...Unknown
-
Suzanna ZickUniversity of MichiganTerminatedQuality of Life | Fatigue | Lupus Erythematosus, Systemic | Sleep | Pain, ChronicUnited States
-
Centers for Disease Control and PreventionCompleted
-
University Hospital, MontpellierCompletedOsteoarthritis | Mindfulness | MBSRFrance
-
Gachon University Gil Oriental Medical HospitalKorea Health Industry Development InstituteCompletedKnee Replacement | AcupunctureKorea, Republic of
-
Mayo ClinicCompleted
-
The Miriam HospitalNational Institute on Aging (NIA)CompletedHeart FailureUnited States
-
Lawson Health Research InstituteUnknownDepression | Quality of Life | Sleep | Anxiety | Dry EyeCanada